Mice develop delayed-type hypersensitivity (DTH) ~ to heterologous red cells provided that dose and route of immunization are appropriately chosen (1). No adjuvant is needed, but the hypersensitivity will be transient and of low intensity if the dose of antigen is too large. For example, the dose of sheep red blood cells (SRBC) which gives maximum antibody production by intravenous immunization causes only a fleeting and barely discernible episode of hypersensitivity. The suppression of DTH is due to blocking factors which are formed by the interaction of antigen and antibody (2). The mediators of DTH can be freed from the influence of this normal inhibitory mechanism by splenectomy (2), by infection with BCG (3), or by treatment with drugs such as cyclophosphamide (CY) which act differentially on B lymphocytes (4-6). Since it was known that DTH reactions tend to be more prolonged in CY-treated animals (7, 8), this drug has been used in the present experiments to investigate the role of antibody in the regulation of T-cell activity.
Materials and MethodsMethods have been described elsewhere for measuring hemagglutinin titers and DTH (2), and lymphoproliferative responses and numbers of plaque-forming cells (PFC) in popliteal lymph nodes (9, 10). The transfer of DTH with dissociated spleen cells has also been described (11).Anlmals.--Specific pathogen-free male and female mice of the CD-1 strain (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) were used at 5 or 6 wk of age. C57BL mice, also from a specific pathogen-free colony, were used in one experiment.Antigens.--SRBC were obtained from the same animal twice weekly. Cells were collected and stored in Alsever's solution at 4°C. They were washed three times with normal saline and suspended to known density by hemacytometer count.